Efficacy and safety in patients with psoriasis treated continuously with adalimumab for approximately 3 years

被引：0
|
作者：
Gordon, Kenneth [1 ]
Sasso, Eric [2 ]
Gu, Yihua [2 ]
Poulin, Yves [3 ]
机构：
[1] NorthShore Univ HealthSystem, Evanston, IL USA
[2] Abbott, Abbott Pk, IL USA
[3] Ctr Dermatol Quebec Metropolitain, Quebec City, PQ, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2010年 / 62卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB140 / AB140
页数：1
相关论文
共 50 条
  • [21] Improvement of Quality of Life in Patients with Psoriasis Being Treated with Adalimumab
    Doerfler, F.
    Schoeberl, A.
    Amon, U.
    AKTUELLE DERMATOLOGIE, 2010, 36 (8-9) : 305 - 308
  • [22] Efficacy and safety of adalimumab are consistent across weight quartiles in patients with moderate to severe psoriasis: Subanalysis of REVEAL
    Menter, Alan
    Gordon, Kenneth
    Goldblum, Orin
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB173 - AB173
  • [23] Paradoxical psoriasis developed in 8 HS patients treated with adalimumab
    Liakou, Aikaterini
    Agiasofitou, Efthymia
    Tsiogka, Aikaterini
    Bonatsou, Konstantina
    Papadakis, Marios
    Papazisi, Maria
    Vladeni, Soultana
    Katoulis, Alexandros
    Stratigos, Alexandros
    Rigopoulos, Dimitrios
    Kontochristopoulos, Georgios
    EXPERIMENTAL DERMATOLOGY, 2022, 31 : 107 - 108
  • [24] Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasis
    Mostafa, N. M.
    Nader, A. M.
    Noertersheuser, P.
    Okun, M.
    Awni, W. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (03) : 490 - 497
  • [25] Adalimumab efficacy and safety results in patients with moderate to severe chronic plaque psoriasis with and without psoriatic arthritis
    Menter, MA
    Gordon, K
    Leonardi, C
    Chen, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P174 - P174
  • [26] Adalimumab efficacy and safety results in patients with moderate to severe chronic plaque psoriasis with and without PsA.
    Menter, MA
    Gordon, KB
    Leonardi, C
    Heffernan, MP
    Chen, DM
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S611 - S612
  • [27] Efficacy and drug survival rates for adalimumab in patients with psoriasis vulgaris
    Suarez Perez, Jorge Alonso
    Herrera, Enrique
    Herrera Acosta, Enrique
    Mendiola Fernandez, Maria Victoria
    Martin Cuervas, Paula
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB168 - AB168
  • [28] EFFICACY AND SAFETY OF SECUKINUMAB IN PATIENTS WITH PSORIASIS
    Su, Q. Y.
    Zhao, B. R.
    Gao, H. J.
    Sun, S. C.
    Luo, J.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1791 - 1792
  • [29] Efficacy and safety of adalimumab 80 mg in the treatment of psoriasis: a bicentric retrospective study
    Sabater-Abad, Javier
    Matellanes-Palacios, Maria
    Bou-Boluda, Laia
    Messeguer-Badia, Francesc
    Agusti-Mejias, Anna
    Velasco-Pastor, Manuel
    Lorente-Fernandez, Laura
    Gimeno-Carpio, Enrique
    DERMATOLOGIC THERAPY, 2020, 33 (03)
  • [30] Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: A systematic review
    Gilbert, Kathleen E.
    Manalo, Iviensan F.
    Wu, Jashin J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (02) : 329 - 331
12345